Control Bionics (ASX:CBL) Equity-to-Asset : 0.73 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Control Bionics's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$6.46 Mil. Control Bionics's Total Assets for the quarter that ended in Dec. 2024 was A$8.84 Mil. Therefore, Control Bionics's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.73.

The historical rank and industry rank for Control Bionics's Equity-to-Asset or its related term are showing as below:

ASX:CBL' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.69 Med: 0.88 Max: 0.96
Current: 0.73

During the past 4 years, the highest Equity to Asset Ratio of Control Bionics was 0.96. The lowest was 0.69. And the median was 0.88.

ASX:CBL's Equity-to-Asset is ranked better than
63.59% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.63 vs ASX:CBL: 0.73

Control Bionics Equity-to-Asset Historical Data

The historical data trend for Control Bionics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Equity-to-Asset Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Equity-to-Asset

0.94

0.89

0.82

0.69

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Equity-to-Asset	Get a 7-Day Free Trial				0.88	0.82	0.86	0.69	0.73

Competitive Comparison of Control Bionics's Equity-to-Asset

For the Medical Devices subindustry, Control Bionics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Control Bionics's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Control Bionics's Equity-to-Asset falls into.

Save Embed

;

Save Embed

;

Control Bionics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Control Bionics's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	6.268	/	9.027
	=	0.69

Control Bionics's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	6.459	/	8.84
	=	0.73

Control Bionics (ASX:CBL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Control Bionics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Control Bionics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.